Hematological morbidity and management in neonates with hemolytic disease due to red cell alloimmunization

MLA

Rath, Mirjam E. A., et al. “Hematological Morbidity and Management in Neonates with Hemolytic Disease Due to Red Cell Alloimmunization.” Early Human Development, vol. 87, no. 9, Sept. 2011, pp. 583–88. EBSCOhost, https://doi.org/10.1016/j.earlhumdev.2011.07.010.

APA

Rath, M. E. A., Smits-Wintjens, V. E. H. J., Walther, F. J., & Lopriore, E. (2011). Hematological morbidity and management in neonates with hemolytic disease due to red cell alloimmunization. Early Human Development, 87(9), 583–588. https://doi.org/10.1016/j.earlhumdev.2011.07.010

Chicago

Rath, Mirjam E.A., Vivianne E.H.J. Smits-Wintjens, Frans J. Walther, and Enrico Lopriore. 2011. “Hematological Morbidity and Management in Neonates with Hemolytic Disease Due to Red Cell Alloimmunization.” Early Human Development 87 (9): 583–88. doi:10.1016/j.earlhumdev.2011.07.010.